Portfolio of Dividend-Paying Pharmaceutical Stocks

Here are 11 major pharmaceutical companies that pay dividends.


11 Dividend-Paying Pharmaceutical Stocks

Stock Return & Price Chart

Symbol

Dividend (Yield) &
Chart

Recent Dividends &
Growth Rate

Abbott LaboratoriesABT$1.28 (1.68%)
AbbVieABBV$4.28 (5.58%)
AmgenAMGN$5.80 (3.48%)
AstraZenecaAZN$3.80 (10.17%)
Bristol-Myers SquibbBMY$1.64 (3.61%)
GlaxoSmithKlineGSK$1.98 (5.12%)
Johnson & JohnsonJNJ$3.80 (2.90%)
LillyLLY$2.58 (2.23%)
MerckMRK$2.20 (2.78%)
Novo NordiskNVO$2.26 (4.80%)
PhizerPFE$1.44 (3.47%)
Dividend data from Quandl as of Jun-01-2019.



To inspect the performance of the Dividend-Paying Pharmaceutical Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 10 stocks included in the portfolio computations are: ABT, AMGN, AZN, BMY, GSK, JNJ, LLY, MRK, NVO and PFE. The current value of the portfolio assumes that $1,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. ABBV was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $192,614. The percent return is 1,826.14%. The annualized return is 28.06%.




Return Summary for Dividend-Paying Pharmaceutical Stocks
Start DateJul-31-2009
Start Investment$6,155.90
End DateJul-19-2019
Current Value of Investment$118,571.00
Total Return1,826.14%
Annualized Return34.42%
Min DateOct-30-2009
Min Price$5,863.84
Max DateJul-19-2019
Max Price$118,571.00
# Values121
Number Returns7,260
Number Profitable Returns6,896
Percent Profitable Returns94.99%
Number Unprofitable Returns364
Percent Unprofitable Returns5.01%
Profitable to Unprofitable Returns Ratio18.95



NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.


Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Generic Drug Stocks